Transplantation KCNMA1 modified bone marrow-mesenchymal stem cell therapy for diabetes mellitus-induced erectile dysfunction

Andrologia

Volumn 46, Issue 5, 2014, Pages 479-486

  He, Y ^a,b   He, W ^a   Qin, G ^a   Luo, J ^a   Xiao, M ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SUINING CENTRAL HOSPITAL   (China)

Author keywords

Diabetes mellitus induced erectile dysfunction; Gene therapy; KCNMA1; Mesenchymal stem cells

Indexed keywords

APOMORPHINE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; LENTIVIRUS VECTOR; PHOSPHATE; STREPTOZOCIN; KCNMA1 PROTEIN, RAT; PRIMER DNA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ERECTILE DYSFUNCTION; FLUORESCENCE MICROSCOPY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTRACAVERNOUS PRESSURE; KCNMA1 GENE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PENIS ERECTION; PRESSURE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL GENE THERAPY; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; COMPLICATION; CYTOLOGY; DIABETES COMPLICATIONS; GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; DIABETES COMPLICATIONS; DNA PRIMERS; ERECTILE DYSFUNCTION; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899582924     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12104     Document Type: Article

References (20)

1. Brink PR, Valiunas V, Wang HZ, Zhao W, Davies K, Christ GJ (2006) Experimental diabetes alters connexin43 derived gap junction permeability in short-term cultures of rat corporeal vascular smooth muscle cells. J Urol 175:381-386.
2. Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L (1993) mSlo, a complex mouse gene encoding"maxi"calcium-activated potassium channels. Science 261:221-224.
3. Christ GJ, Andersson KE, Williams K, Zhao W, D'Agostino R Jr, Kaplan J, Aboushwareb T, Yoo J, Calenda G, Davies KP, Sellers RS, Melman A (2009) Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol 56:1055-1066.
4. Fridenstein A, Piatetskii S, Petrakova KV (1969) Osteogenesis in transplants of bone marrow cells. Arkh Anat GistoI Embriol 56:3-11.
5. Ghatta S, Nimmagadda D, Xu X, O'Rourke ST (2006) Large conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 110:103-116.
6. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG (2010) Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 7:445-475.
7. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E; European Association of Urology (2010) Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 57:804-814.
8. Jamnig A, Lepperdinger G (2012) From tendon to nerve: an MSC for all seasons. Can J Physiol Pharmacol 90:295-306.
9. Koi PT, Milhoua PM, Monrose V, Melman A, DiSanto ME (2007) Expression of myosin isoforms in the smooth muscle of human corpus cavernosum. Int J Impot Res 19:62-68.
10. Lin G, Qiu X, Fandel T, Banie L, Wang G, Lue TF, Lin CS (2011) Tracking intracavernously injected adipose-derived stem cells to bone marrow. Int J Impot Res 23:268-275.
11. Nangle MR, Cotter MA, Cameron NE (2004) Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol 502:143-148.
12. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF (2003) Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction(EXCEED) database. Diabetes Care 26:1093-1099.
13. Qiu X, Sun C, Yu W, Lin H, Sun Z, Chen Y, Wang R, Dai Y (2012) Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J Androl 33:37-44.
14. Rendell MS, Rajfer J, Wicker PA, Smith MD (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 281:421-426.
15. Salkoff L, Butler A, Ferreira G, Santi C, Wei A (2006) High-conductance potassium channels of the SLO family. Nat Rev Neurosci 7:921-931.
16. Setter SM, Iitz JL, Fincham JE, Campbell RK, Baker DE (2005) Phosphodiesterase 5 inhibitors for erectile dysfunction. Ann Pharmacother 39:1286-1295.
17. Shabsigh R (2004) Therapy of ED: PDE-5 Inhibitors. Endocrine 23:135-141.
18. Song YS, Lee HJ, Park IH, Kim WK, Ku JH, Kim SU (2007) Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res 19:378-385.
19. Wespes E, Amar E, Hatzichristou DG, Montorsi F, Pryor J, Vardi Y (2002) European Association of Urology Guidelines on erectile dysfunction. Eur Urol 41:1-5.
20. Zotova EG, Schaumburg HH, Raine CS, Cannella B, Tar M, Melman A, Arezzo JC (2008) Effects of hyperglycemia on rat cavernous nerve axons: a functional and ultrastructural study. Exp Neurol 213:439-447.